Semaglutide has emerged as a promising treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and curbing glucagon https://rebeccaytxg973867.prublogger.com/34790503/grasping-semaglutide-a-comprehensive-guide